Characteristics of patients with pituitary gigantism : results of an international study; Daly, Adrian ; et alin Endocrine abstracts - 15th European Congress of Endocrinology (2013, May) Detailed reference viewed: 7 (1 ULg) Caracteristicas de prolactinomas resisitentes a dosis estandar de cabergolina : un estudio multicentrico en 92 pacientesBeckers, Albert ; ; VROONEN, Laurent et alin Abstract book - 54 Congreso Sociedad Espanola de Endocrinologia y nutrition (2012, May 23) Detailed reference viewed: 9 (0 ULg) Clinical characterization of cabergoline resistant prolactinomas : a multicenter experience on 92 patientsVROONEN, Laurent ; ; PETROSSIANS, Patrick et alin Annales d'Endocrinologie (2012, April), 73(2), 153 Detailed reference viewed: 20 (2 ULg) Clinical and genetic aspects of Familial Isolated Pituitary Adenomas; ; et al in Clinics (2012) Detailed reference viewed: 20 (6 ULg) Impact des mutations germinales du gène AIP sur les caractéristiques tumorales et la prise en charge médicale chez les patients acromégales jeunes : résultats d'une étude sur des populations appariées pour l'âge et le diamètre de la tumeurBeckers, Albert ; ; et alin Annales d'Endocrinologie - 28ème congrès de la société Française d'Endocrinologie (2011) Detailed reference viewed: 15 (0 ULg) Strategies for screening and management of Familial Isolated Pituitary Adenomas (FIPA) : Our experience on 17 families in a single center in Brazil; ; et al in Abstract book - Endo 2011 (2011) Detailed reference viewed: 5 (0 ULg) Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas - An International Collaborative StudyDaly, Adrian ; ; Petrossians, Patrick et alin Journal of Clinical Endocrinology and Metabolism (2010), 95(11), Context: AIP mutations (AIPmut) give rise to a pituitary adenoma predisposition that occurs in familial isolated pituitary adenomas and less often in sporadic cases. The clinical and therapeutic features ... [more ▼] Context: AIP mutations (AIPmut) give rise to a pituitary adenoma predisposition that occurs in familial isolated pituitary adenomas and less often in sporadic cases. The clinical and therapeutic features of AIPmut-associated pituitary adenomas have not been studied comprehensively. Objective: The objective of the study was to assess clinical/therapeutic characteristics of AIPmut pituitary adenomas. Design: This study was an international, multicenter, retrospective case collection/database analysis. Setting: The study was conducted at 36 tertiary referral endocrine and clinical genetics departments. Patients: Patients included 96 patients with germline AIPmut and pituitary adenomas and 232 matched AIPmut-negative acromegaly controls. Results: The AIPmut population was predominantly young and male (63.5%); first symptoms occurred as children/adolescents in 50%. At diagnosis, most tumors were macroadenomas (93.3%); extension and invasion was common. Somatotropinomas comprised 78.1% of the cohort; there were also prolactinomas (n = 13), nonsecreting adenomas (n = 7), and a TSH-secreting adenoma. AIPmut somatotropinomas were larger (P = 0.00026), with higher GH levels (P = 0.00068), more frequent extension (P = 0.018) and prolactin cosecretion (P = 0.00023), and occurred 2 decades before controls (P < 0.000001). Gigantism was more common in the AIPmut group (P < 0.000001). AIPmut somatotropinoma patients underwent more surgical interventions (P = 0.00069) and had lower decreases in GH (P = 0.00037) and IGF-I (P = 0.028) and less tumor shrinkage with somatostatin analogs (P < 0.00001) vs. controls. AIPmut prolactinomas occurred generally in young males and frequently required surgery or radiotherapy. Conclusions: AIPmut pituitary adenomas have clinical features that may negatively impact treatment efficacy. Predisposition for aggressive disease in young patients, often in a familial setting, suggests that earlier diagnosis of AIPmut pituitary adenomas may have clinical utility. [less ▲] Detailed reference viewed: 66 (33 ULg) Caractéristiques cliniques et réponses thérapeutiques des patients avec adénome hypophysaire mutés pour AIP : étude internationale sur 96 casBeckers, Albert ; Daly, Adrian ; Petrossians, Patrick et alin Annales d'Endocrinologie (2010, September), 71(5), 346 Detailed reference viewed: 12 (2 ULg) Caractéristiques des prolactinomes résistants aux agonistes dopaminergiquesVroonen, Laurent ; ; et alin Annales d'Endocrinologie (2010, September), 71(5), 347 Detailed reference viewed: 24 (3 ULg) Caractérisation des facteurs associés à la perte d'expression de AIP dans les adénomes hypophysaires somatotropes; ; et al in Annales d'Endocrinologie (2010, September), 71(5), 406 Detailed reference viewed: 17 (8 ULg) Recherche de la mutation du gène CDKN1B dans les adénomes hypophysaires familiaux isolés (FIPA): analyse de 86 famillesBeckers, Albert ; ; et alin Annales d'Endocrinologie (2010, September), 71(5), 398 Detailed reference viewed: 13 (5 ULg) An aggressive, treatment-resistant prolactinoma in a child with a germline mutation in the aryl hydrocarbon receptor interacting protein (AIP) gene; ; et al in European Neuroendocrine Association - Liège, 22-25 septembre 2010 (2010, September) Detailed reference viewed: 10 (2 ULg) Hyperplasia of Intermediate Lobe may be related to mutation in the Aryl Hydrocarbon Protein Gene in a Context of Familial Isolated Pituitary Adenoma (FIPA); ; Daly, Adrian et alin European Neuroendocrine Association - Liège, 22-25 septembre 2010 (2010, September) Detailed reference viewed: 6 (1 ULg) Caractérisation des facteurs associés à la perte d'expression de AIP dans les adénomes hypophysaires somatotropes; ; et al in 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September) Detailed reference viewed: 23 (13 ULg) Caractéristiques cliniques et réponses thérapeutiques des patients avec adénome hypophysaire mutés pour AIP : étude internationale sur 96 casBeckers, Albert ; Daly, Adrian ; Petrossians, Patrick et alin 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September) Detailed reference viewed: 10 (2 ULg) Comprehensive study about the characteristics of 80 dopaminergic agonist resistants prolactinomasVroonen, Laurent ; ; et alin European Neuroendocrine Association - Liège, 22-25 septembre 2010 (2010, September) Detailed reference viewed: 16 (5 ULg) Recherche de la mutation du gène CDKN1B dans les adénomes hypophysaires familiaux isolés (FIPA) : analyse de 86 famillesBeckers, Albert ; ; et alin 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September) Detailed reference viewed: 22 (10 ULg) Familial pituitary adenomas; ; Vroonen, Laurent et alin Annales d'Endocrinologie (2010), 71 Detailed reference viewed: 25 (21 ULg) Aggressive prolactinoma in a child related to germline mutation in the Aryl Hydrocarbon receptor interacting protein (AIP) gene; ; et al in Arquivos Brasileiros de Endocrinologia e Metabologia (2010), 54(8), 761-767 Detailed reference viewed: 6 (1 ULg) Cyclin dependant kinase inhibitor 1B (CDKN1B) gene mutations in familial isolated pituitary adenomas (FIPA) : Analysis in 86 families; ; Daly, Adrian et alin 52 Symposium der Deutschen Gesellschaft für Endokrinologie (2009, March) Detailed reference viewed: 5 (1 ULg) |
||